An agenda built through deep collaboration with our community to ensure every session delivers substance over soundbites. You’ll hear from true subject matter leaders via candid case studies, collaborative roundtables, and varied panel discussions —providing clarity on what’s driving success across the customer engagement landscape
• Equip senior leaders with AI literacy through interactions with AI champions to truly understand the impact new tech has across the commercial lifecycle.
• Prove technology ROI and accelerate scale by aligning leadership and frontline teams through shared commercial data visibility to close the gap between those buying the tech and those using it.
Daniele Iacovelli, SVP, Global Head Roche Digital Technology Pharma Medicines, Roche
• Experience and change management: How reviewers went from sceptical to confident.
Impact: What it meant for the business, beyond the review queue.
• Lessons learned: What worked, what didn't, and what we'd do differently.
Oliver Cockayne, Digital & Commercial Product Manager UK & IE, Ferring UK and Ireland
William McCully, Co-Founder & Director, Aithena
- Deliver measurable cost savings and productivity gains by building a board-ready ROI narrative grounded in revenue figures and commercial outcomes that justifies scaling AI from experiment to enterprise
- Pinpoint where AI investment pays off and where it stalls by benchmarking against defined commercial metrics, so you can decide faster what to prioritise and how to turn pilots into scaled results
Diana Medeiros Placido, CDTO, ViiV Healthcare
Shreenivasa Rajanala, VP, Data, Analytics and AI, Global Commercialisation, Bayer
Chad Lacrosse, Vice President, Global Commercial BTS, Abbvie
Rakesh Kantaria, Founder, Circuit Medical
- Accelerate commercial AI performance by closing the organisational adoption gap, turning field force sceptics into confident, productive users who deliver ROI from day one
- Transform leadership from adoption obstacles into adoption engines by equipping department heads with the AI literacy and accountability structures that embed technology into daily workflows
Eva Martins, SVP, Commercial Excellence & Strategic Insights, Merck
Sabine Louet, CEO, SciencePod
- Move beyond efficiency as the goal and use AI to redesign how decisions are made across your organisation
- Shift competitive advantage from access to technology to the human capabilities that create value: judgment, creativity and critical thinking
- Create more agile organisations by enabling smaller, earlier and better-informed decisions closer to the customer and the market
Â
Vinoth Manoharan, Head of Innovation, Syneos Health
Andreas Reinbolz, Managing Director, Communications, Syneos Health
- Power the launch execution with data architecture that connects marketing, sales, and customer-facing data within a single database
- Deploy highly accurate commercial AI by implementing customer interaction capture tools that convert real-time behavioural data into next-best-action decisions for your CX teams
Svetoslav Tsenov, General Manager, Bulgaria, Hungary, Romania, and Greece, Astellas
Anne - Sophie Huet, Global Head, Go-To-Market, Strategy & Transformation, Sanofi
Sabine Louet, CEO, SciencePod
- Deliver decisive field performance by arming reps with live CRM intelligence rather than yesterday's batch data, because in a competitive HCP landscape, seconds matter
- Strengthen omnichannel coordination by feeding real-time field signals back into the CRM to create a continuously self-improving recommendation enginee
Hugo Barbossa, EU Customer Omnichannel Director, ViiV Healthcare
This 60-minute working session is designed for pharma data, technology, and commercial leaders who are ready to move beyond experimentation and build AI programmes that scale. Drawing on cross-sector insight from Wavestone and the real-world challenges CSL has worked through, the session combines structured group work with practitioner-led discussion to turn AI potential into executable, outcome-focused plans.
- Unlock scalable AI impact by assessing AI readiness across the people, process, and data conditions, from AI literacy to data foundations, that separate high-performing pharma AI programmes from those that stall at proof of concept
- Forge an implementation roadmap grounded in live programme experience, including what worked at CSL in use-case prioritisation, what slowed progress, and which pitfalls recur across the sector
Jalilah Gibson, Partner, Wavestone
Sihame Bahri, Global Omnichannel Engagement Lead Nephrology and Iron Portfolios, CSL
Callum Lyons, SME AI, Wavestone
- Transform your database from a passive activity log into an active commercial engine, delivering prioritised HCP recommendations and real-time opportunity signals at the point of engagement, from pre-launch through to peak sales
- Close the gap between commercial strategy and field reality with connected data and analytics to create interactions that shift prescribing behaviour and protect revenue at scale
Necati Sebe, Senior Director, Field Force and Digital Transformation, International Markets, GSK
Luca Magri, Head of Strategy, Excellence & Innovation, Bayer
Sree Bhagyadutt Dodda, Director, HCP Engagements, Novo Nordisk
Kruti Popat, Director, Customer Experience, Boehringer Ingelheim
Anders Burdett, Managing Partner, The Pharma Data Lab
- Improve AI answer accuracy by identifying the business context, rules, and data foundations that transform generic assistants into commercial intelligence agents
- Discover the highest-value semantic and process enrichments that enable AI to deliver more relevant, trusted, and actionable insights.
Heath Durrans, Director of Commercial Pharma, C&F
- Accelerate HCP engagement quality by deploying AI as the behind-the-scenes analyst, surfacing timely, accurate insights so field teams walk into every conversation fully prepared
- Embed a human-first engagement model that preserves rep authority and clinical trust, while using clean, harmonised data to power next-best-action at the individual HCP level
Ayesha Aziz-Akosa, Head of Global Marketing, Established Brands, AstellasÂ
- Unlock real-time insights into clinical decision-making by capturing behavioural data at the point of care to reveal why HCPs choose specific treatments before a decision is made
- Gain access to 86,000+ physicians and pharmacists' real-time decisions through AI co-pilot data to reveal cross-setting treatment patterns in seasonal diseases, uncovering market gaps invisible in traditional data sources.
- This session will show what becomes visible when bridging these two HCP populations, using seasonal diseases as an example, relevant to both pharma and consumer health, benchmarked against publicly available data.
Daniela Seixas, CEO, Tonic
Bespoke beats off-the-rack: Build channel-ready HCP profiles that fit every prescriber, not every segment
- Optimise omnichannel execution by unifying prescribing behaviour, engagement history, and real-time market signals into AI-powered HCP profiles that deliver personalised content from launch onwards
- Give field and marketing teams the analytics tools to act with confidence, connecting clean HCP intelligence to prescription impact across every channel
Â
Sihame Bahri, Global Omnichannel Engagement Lead Nephrology and Iron Portfolios, CSL
William Fraser, Head of Marketing UK, Roche
Rory Scanes, Head of AI Enablement and Established Brands, Boehringer Ingelheim
Jonathan Elliot, Content Lead, Reuters Events Pharma
- Discover practical ways to use AI in your day-to-day role; reducing administrative burden, accelerating content creation, and improving planning, analysis and communication, so you can spend more time on strategic, high-value work.
- Build confidence in integrating AI into your work and teams through real-world examples, practical prompts and lessons that professionals across pharma, biotech and allied healthcare can apply immediately.
- Use AI to support personal and professional development by accelerating learning, strengthening leadership, improving decision-making and creating more capacity for the work that matters most.
- Explore where human strengths remain essential, and how leadership, influence, relationship-building, critical thinking, creativity and professional judgement can be amplified, not replaced, by AI.
Clare Hillman, President of Education and Events - Northern Europe, Healthcare Businesswomen's Association
Helen Taylor, Chair, Northern Europe, Healthcare Businesswoman's Association
Sarah Seager, EMEA & APAC Community of Practice Co-Lead, HBA
- Equip commercial leaders with an investment governance framework by mapping how AI budget authority flows across brand, field force, and digital functions so the right conversations happen with the right stakeholders before the next planning cycle.
- Drive ROI accountability by replacing vague efficiency claims with a defined commercial AI measurement framework linked to HCP engagement quality, field force productivity, and revenue impact.Â
Riccardo Calliano, VP Finance, GenAI Commercial Investments, GSK
Why System 3 thinking is rewriting the rules of HCP engagement
- Meet pharma's new decision-making reality: Discover how many HCPs are already using generative AI in clinical practice and say it influences their treatment decisions, according to new research from Remedy Edge.
- Move beyond the human brain: Explore the rise of System 3 thinking and why the messages that persuade HCPs aren't necessarily the ones that influence AI-generated answers.
- Win the battle for AI recommendations: Learn how pharma brands can run Generative Engine Optimisation (GEO) with our solution Radar to improve their visibility, accuracy and positioning in LLM responses, with particular considerations for European and international markets.
Yavuz Dilmac, Strategy Partner, Remedy Edge
- Unlock scalable, compliant content generation by unifying clinical insights, customer data, and engagement analytics through AI-ready infrastructure that enables personalised HCP communications across every therapeutic area and channel
- Accelerate content production and deployment by implementing generative AI tools and martech platforms that transform fragmented medical and commercial data into targeted campaign assets, educational materials, and omnichannel touchpoints at speed
Vicky Ngo, AVP, International Lead, Digital Human Health, MSD
Nisha Paliwal, Vice President, Commercial BTS Data and AI, Abbvie
Claudio Cipriani, Head of Global Commercial Services, Organon
Andrea Pagliai, Global Managing Director and Vice President, NTT DATA
- Move beyond fragmented data infrastructure and make the real architectural decisions that transform your commercial data from a liability into a scalable AI asset
- Define the cross-functional ownership structures and quality standards that give your organisation the confidence to deploy AI across commercial workflows at speed
- Help uncover the bottlenecks and hidden opportunities across the end-to-end content lifecycle, and reimagine how insights become personalised, HCP-ready content at the speed of the market.
- Discover how AI agents for decision intelligence and content creation turn a single insight into a compliant, ready-to-use asset, live.
Jens Horneman SVP, Strategy & Customer Success, Hyntelo
Luigi Cammi CSO Life Sciences, Hyntelo
Tomás Vicente International Business Development Manager, Hyntelo
- Transform field force output by deploying AI co-workers that handle pre-call planning, opportunity surfacing, insight capture and post-call administration as a seamless part of the commercial workflow
- Strengthen HCP coverage and personalisation at scale by enabling human led AI to maintain compliant engagement with doctors and pharmacists across brands and markets
- Embed AI execution into commercial operations as a scalable, ROI-measured workforce layer
Â
David Maso, CEO, Avatia
- Cut through the complexity of multi-agent architecture by understanding what infrastructure, protocols, and governance frameworks are needed to move agentic AI from isolated pilots into coordinated, enterprise-scale commercial operations
- Ensure your agents do only what they should by building the security guardrails, observability layers, and human-in-the-loop controls that make agentic AI trustworthy enough to embed into regulated commercial workflows
Sudeep Gupta, Global Head of Data, Kyowa Kirin
Marion Legler, Head of Pharma Decision Science & AI, Bayer
Vaibhav Kabra, Senior Director - AI Products and Innovation, Novartis
Chiara Bolognini, Global CJ Marketing & Sales, Roche
- Interrogate the real numbers behind successful enterprise AI deployments and the specific investment decisions that freed commercial teams to spend more time where it matters: engaging HCPs and patients
- Replicate the commercial frameworks and leadership conditions that converted AI experimentation into measurable launch impact, and apply them across your own enterprise to accelerate market penetration
Margi Sheth, Head, AI Governance & Enablement, Novo Nordisk
Cyril Mandry, International Head, Oncology Customer Engagement & Omnichannel Experience, MSD
Marina Borozna, Head of Data and AI Strategy, Ipsen
Tinkara Pavlovcic Kapitanovic, Global Marketing Operations Responsible - Global Commercial Development, Viatris
- Reach more HCPs and drive greater commercial impact by translating your AI pilot results into the revenue influence, efficiency gains, and patient outcome narratives that compel leadership to fund enterprise-wide expansion
- Secure that investment by expanding your early adopter base, presenting cost-saving evidence, and equipping champions with the frameworks to accelerate stakeholder sign-off before the window closes
- Ensure sound infrastructure, clean data pipelines, and seamless workflow integration to eliminate the failure points that have typically stopped AI projects from ever reaching the field
- Demonstrate ROI measurement frameworks and adoption tooling that give commercial and data leaders evidence to secure executive buy-in, accelerate cross-functional rollout, and sustain AI performance at scale
Mohammed Abdelkader, Global Director - AI Assisted Training & Development Expert / Global CL&D / AI VT Captain, Astellas
• Equip senior leaders with AI literacy through interactions with AI champions to truly understand the impact new tech has across the commercial lifecycle.
• Prove technology ROI and accelerate scale by aligning leadership and frontline teams through shared commercial data visibility to close the gap between those buying the tech and those using it.
Daniele Iacovelli, SVP, Global Head Roche Digital Technology Pharma Medicines, Roche
• Experience and change management: How reviewers went from sceptical to confident.
Impact: What it meant for the business, beyond the review queue.
• Lessons learned: What worked, what didn't, and what we'd do differently.
Â
Oliver Cockayne, Digital & Commercial Product Manager UK & IE, Ferring UK and Ireland
William McCully, Co-Founder & Director, Aithena
- Deliver measurable cost savings and productivity gains by building a board-ready ROI narrative grounded in revenue figures and commercial outcomes that justifies scaling AI from experiment to enterprise
- Pinpoint where AI investment pays off and where it stalls by benchmarking against defined commercial metrics, so you can decide faster what to prioritise and how to turn pilots into scaled results
Diana Medeiros Placido, CDTO, ViiV Healthcare
Shreenivasa Rajanala, VP, Data, Analytics and AI, Global Commercialisation, Bayer
Chad Lacrosse, Vice President, Global Commercial BTS, Abbvie
Rakesh Kantaria, Founder, Circuit Medical
- Accelerate commercial AI performance by closing the organisational adoption gap, turning field force sceptics into confident, productive users who deliver ROI from day one
- Transform leadership from adoption obstacles into adoption engines by equipping department heads with the AI literacy and accountability structures that embed technology into daily workflows
Â
Eva Martins, SVP, Commercial Excellence & Strategic Insights, Merck
Sabine Louet, CEO, SciencePod
- Move beyond efficiency as the goal and use AI to redesign how decisions are made across your organisation
- Shift competitive advantage from access to technology to the human capabilities that create value: judgment, creativity and critical thinking
- Create more agile organisations by enabling smaller, earlier and better-informed decisions closer to the customer and the market
Vinoth Manoharan, Head of Innovation, Syneos Health
Andreas Reinbolz, Managing Director, Communications, Syneos Health
- Power the launch execution with data architecture that connects marketing, sales, and customer-facing data within a single database
- Deploy highly accurate commercial AI by implementing customer interaction capture tools that convert real-time behavioural data into next-best-action decisions for your CX teams
Svetoslav Tsenov, General Manager, Bulgaria, Hungary, Romania, and Greece, Astellas
Anne - Sophie Huet, Global Head, Go-To-Market, Strategy & Transformation, Sanofi
Sabine Louet, CEO, SciencePod
- Discover practical ways to use AI in your day-to-day role; reducing administrative burden, accelerating content creation, and improving planning, analysis and communication, so you can spend more time on strategic, high-value work.
- Build confidence in integrating AI into your work and teams through real-world examples, practical prompts and lessons that professionals across pharma, biotech and allied healthcare can apply immediately.
- Use AI to support personal and professional development by accelerating learning, strengthening leadership, improving decision-making and creating more capacity for the work that matters most.
- Explore where human strengths remain essential, and how leadership, influence, relationship-building, critical thinking, creativity and professional judgement can be amplified, not replaced, by AI.
Â
Clare Hillman, President of Education and Events - Northern Europe, Healthcare Businesswomen's Association
Helen Taylor, Chair, Northern Europe, Healthcare Businesswoman's Association
Sarah Seager, EMEA & APAC Community of Practice Co-Lead, HBA
- Equip commercial leaders with an investment governance framework by mapping how AI budget authority flows across brand, field force, and digital functions so the right conversations happen with the right stakeholders before the next planning cycle.
- Drive ROI accountability by replacing vague efficiency claims with a defined commercial AI measurement framework linked to HCP engagement quality, field force productivity, and revenue impact.Â
Riccardo Calliano, VP Finance, GenAI Commercial Investments, GSK
Why System 3 thinking is rewriting the rules of HCP engagement
- Meet pharma's new decision-making reality: Discover how many HCPs are already using generative AI in clinical practice and say it influences their treatment decisions, according to new research from Remedy Edge.
- Move beyond the human brain: Explore the rise of System 3 thinking and why the messages that persuade HCPs aren't necessarily the ones that influence AI-generated answers.
- Win the battle for AI recommendations: Learn how pharma brands can run Generative Engine Optimisation (GEO) with our solution Radar to improve their visibility, accuracy and positioning in LLM responses, with particular considerations for European and international markets.
Â
Yavuz Dilmac, Strategy Partner, Remedy Edge
- Unlock scalable, compliant content generation by unifying clinical insights, customer data, and engagement analytics through AI-ready infrastructure that enables personalised HCP communications across every therapeutic area and channel
- Accelerate content production and deployment by implementing generative AI tools and martech platforms that transform fragmented medical and commercial data into targeted campaign assets, educational materials, and omnichannel touchpoints at speed
Vicky Ngo, AVP, International Lead, Digital Human Health, MSD
Nisha Paliwal, Vice President, Commercial BTS Data and AI, Abbvie
Claudio Cipriani, Head of Global Commercial Services, Organon
Andrea Pagliai, Global Managing Director and Vice President, NTT DATA
- Deliver decisive field performance by arming reps with live CRM intelligence rather than yesterday's batch data, because in a competitive HCP landscape, seconds matter
- Strengthen omnichannel coordination by feeding real-time field signals back into the CRM to create a continuously self-improving recommendation enginee
Hugo Barbossa, EU Customer Omnichannel Director, ViiV Healthcare
This 60-minute working session is designed for pharma data, technology, and commercial leaders who are ready to move beyond experimentation and build AI programmes that scale. Drawing on cross-sector insight from Wavestone and the real-world challenges CSL has worked through, the session combines structured group work with practitioner-led discussion to turn AI potential into executable, outcome-focused plans.
Â
- Unlock scalable AI impact by assessing AI readiness across the people, process, and data conditions, from AI literacy to data foundations, that separate high-performing pharma AI programmes from those that stall at proof of concept
- Forge an implementation roadmap grounded in live programme experience, including what worked at CSL in use-case prioritisation, what slowed progress, and which pitfalls recur across the sector
Â
Jalilah Gibson, Partner, Wavestone
Sihame Bahri, Global Omnichannel Engagement Lead Nephrology and Iron Portfolios, CSL
Callum Lyons, SME AI, Wavestone
- Transform your database from a passive activity log into an active commercial engine, delivering prioritised HCP recommendations and real-time opportunity signals at the point of engagement, from pre-launch through to peak sales
- Close the gap between commercial strategy and field reality with connected data and analytics to create interactions that shift prescribing behaviour and protect revenue at scale
Necati Sebe, Senior Director, Field Force and Digital Transformation, International Markets, GSK
Luca Magri, Head of Strategy, Excellence & Innovation, Bayer
Sree Bhagyadutt Dodda, Director, HCP Engagements, Novo Nordisk
Kruti Popat, Director, Customer Experience, Boehringer Ingelheim
- Help uncover the bottlenecks and hidden opportunities across the end-to-end content lifecycle, and reimagine how insights become personalised, HCP-ready content at the speed of the market.
- Discover how AI agents for decision intelligence and content creation turn a single insight into a compliant, ready-to-use asset, live.
Â
Jens Horneman SVP, Strategy & Customer Success, Hyntelo
Luigi Cammi CSO Life Sciences, Hyntelo
Tomás Vicente International Business Development Manager, Hyntelo
- Accelerate HCP engagement quality by deploying AI as the behind-the-scenes analyst, surfacing timely, accurate insights so field teams walk into every conversation fully prepared
- Embed a human-first engagement model that preserves rep authority and clinical trust, while using clean, harmonised data to power next-best-action at the individual HCP level
Ayesha Aziz-Akosa, Head of Global Marketing, Established Brands, AstellasÂ
- Unlock real-time insights into clinical decision-making by capturing behavioural data at the point of care to reveal why HCPs choose specific treatments before a decision is made
- Gain access to 86,000+ physicians and pharmacists' real-time decisions through AI co-pilot data to reveal cross-setting treatment patterns in seasonal diseases, uncovering market gaps invisible in traditional data sources.
- This session will show what becomes visible when bridging these two HCP populations, using seasonal diseases as an example, relevant to both pharma and consumer health, benchmarked against publicly available data.
Â
Daniela Seixas, CEO, Tonic
Bespoke beats off-the-rack: Build channel-ready HCP profiles that fit every prescriber, not every segment
- Optimise omnichannel execution by unifying prescribing behaviour, engagement history, and real-time market signals into AI-powered HCP profiles that deliver personalised content from launch onwards
- Give field and marketing teams the analytics tools to act with confidence, connecting clean HCP intelligence to prescription impact across every channel
Sihame Bahri, Global Omnichannel Engagement Lead Nephrology and Iron Portfolios, CSL
William Fraser, Head of Marketing UK, Roche
Rory Scanes, Head of AI Enablement and Established Brands, Boehringer Ingelheim
Jonathan Elliot, Content Lead, Reuters Events Pharma
- Move beyond fragmented data infrastructure and make the real architectural decisions that transform your commercial data from a liability into a scalable AI asset
- Define the cross-functional ownership structures and quality standards that give your organisation the confidence to deploy AI across commercial workflows at speed
- Transform field force output by deploying AI co-workers that handle pre-call planning, opportunity surfacing, insight capture and post-call administration as a seamless part of the commercial workflow
- Strengthen HCP coverage and personalisation at scale by enabling human led AI to maintain compliant engagement with doctors and pharmacists across brands and markets
- Embed AI execution into commercial operations as a scalable, ROI-measured workforce layer
Â
David Maso, CEO, Avatia
- Cut through the complexity of multi-agent architecture by understanding what infrastructure, protocols, and governance frameworks are needed to move agentic AI from isolated pilots into coordinated, enterprise-scale commercial operations
- Ensure your agents do only what they should by building the security guardrails, observability layers, and human-in-the-loop controls that make agentic AI trustworthy enough to embed into regulated commercial workflows
Sudeep Gupta, Global Head of Data, Kyowa Kirin
Marion Legler, Head of Pharma Decision Science & AI, Bayer
Vaibhav Kabra, Senior Director - AI Products and Innovation, Novartis
Chiara Bolognini, Global CJ Marketing & Sales, Roche
- Interrogate the real numbers behind successful enterprise AI deployments and the specific investment decisions that freed commercial teams to spend more time where it matters: engaging HCPs and patients
- Replicate the commercial frameworks and leadership conditions that converted AI experimentation into measurable launch impact, and apply them across your own enterprise to accelerate market penetration
Margi Sheth, Head, AI Governance & Enablement, Novo Nordisk
Cyril Mandry, International Head, Oncology Customer Engagement & Omnichannel Experience, MSD
Marina Borozna, Head of Data and AI Strategy, Ipsen
Tinkara Pavlovcic Kapitanovic, Global Marketing Operations Responsible - Global Commercial Development, Viatris
- Reach more HCPs and drive greater commercial impact by translating your AI pilot results into the revenue influence, efficiency gains, and patient outcome narratives that compel leadership to fund enterprise-wide expansion
- Secure that investment by expanding your early adopter base, presenting cost-saving evidence, and equipping champions with the frameworks to accelerate stakeholder sign-off before the window closes
- Ensure sound infrastructure, clean data pipelines, and seamless workflow integration to eliminate the failure points that have typically stopped AI projects from ever reaching the field
- Demonstrate ROI measurement frameworks and adoption tooling that give commercial and data leaders evidence to secure executive buy-in, accelerate cross-functional rollout, and sustain AI performance at scale
Â
Mohammed Abdelkader, Global Director - AI Assisted Training & Development Expert / Global CL&D / AI VT Captain, Astellas
This 60-minute working session is designed for pharma data, technology, and commercial leaders who are ready to move beyond experimentation and build AI programmes that scale. Drawing on cross-sector insight from Wavestone and the real-world challenges CSL has worked through, the session combines structured group work with practitioner-led discussion to turn AI potential into executable, outcome-focused plans.
- Unlock scalable AI impact by assessing AI readiness across the people, process, and data conditions, from AI literacy to data foundations, that separate high-performing pharma AI programmes from those that stall at proof of concept
- Forge an implementation roadmap grounded in live programme experience, including what worked at CSL in use-case prioritisation, what slowed progress, and which pitfalls recur across the sector
Jalilah Gibson, Partner, Wavestone
Sihame Bahri, Global Omnichannel Engagement Lead Nephrology and Iron Portfolios, CSL
Callum Lyons, SME AI, Wavestone
- Improve AI answer accuracy by identifying the business context, rules, and data foundations that transform generic assistants into commercial intelligence agents
- Discover the highest-value semantic and process enrichments that enable AI to deliver more relevant, trusted, and actionable insights.
Heath Durrans, Director of Commercial Pharma, C&F
- Discover practical ways to use AI in your day-to-day role; reducing administrative burden, accelerating content creation, and improving planning, analysis and communication, so you can spend more time on strategic, high-value work.
- Build confidence in integrating AI into your work and teams through real-world examples, practical prompts and lessons that professionals across pharma, biotech and allied healthcare can apply immediately.
- Use AI to support personal and professional development by accelerating learning, strengthening leadership, improving decision-making and creating more capacity for the work that matters most.
- Explore where human strengths remain essential, and how leadership, influence, relationship-building, critical thinking, creativity and professional judgement can be amplified, not replaced, by AI.
Â
Clare Hillman, President of Education and Events - Northern Europe, Healthcare Businesswomen's Association
Helen Taylor, Chair, Northern Europe, Healthcare Businesswoman's Association
Sarah Seager, EMEA & APAC Community of Practice Co-Lead, HBAÂ
- Help uncover the bottlenecks and hidden opportunities across the end-to-end content lifecycle, and reimagine how insights become personalised, HCP-ready content at the speed of the market.
- Discover how AI agents for decision intelligence and content creation turn a single insight into a compliant, ready-to-use asset, live.
Â
Jens Horneman SVP, Strategy & Customer Success, Hyntelo
Luigi Cammi CSO Life Sciences, Hyntelo
Tomás Vicente International Business Development Manager, Hyntelo